Literature DB >> 2319322

The role of hemoglobin in arterial narrowing after subarachnoid hemorrhage.

M R Mayberg1, T Okada, D H Bark.   

Abstract

A porcine model for subarachnoid hemorrhage has been developed to allow the selective application of blood and its components to cerebral arteries. Whole blood was centrifuged to produce two fractions consisting of washed erythrocytes (red blood cells, RBC's) and white blood cells (WBC) plus platelet-rich plasma (PRP); the RBC fraction was subsequently separated into hemoglobin (Hb)-containing cytosol and erythrocyte membranes. Each fraction was selectively applied to the middle cerebral artery (MCA) of pigs for 10 days; after which, vessels were perfusion-fixed and examined by light and transmission electron microscopy and immunohistochemical studies. By morphometric analysis, a marked reduction in the MCA lumen cross-sectional area was observed after selective application of RBC's or Hb/cytosol but not of WBC/PRP or erythrocyte membranes. In both RBC- and Hb/cytosol-treated vessels, luminal narrowing was associated with a differential increase in vessel wall thickness of the ventral (subarachnoid) compared to the dorsal (brain) aspect of the artery, but no significant change in cross-sectional area of the vessel wall. After 10 days of exposure to RBC's or Hb/cytosol, there was a spectrum of ultrastructural changes in the vessel wall comparable to those seen after periadventitial application of whole blood. Selective application of commercially available Hb to MCA produced similar structural and morphometric changes. The degree of luminal narrowing after exposure to whole blood or RBC's was proportional to the volume of the erythrocyte mass adjacent to the vessel at sacrifice. These data suggest that arterial narrowing after SAH is mediated by mechanisms related to prolonged exposure of the vessel wall to hemoglobin or its catabolites from lysing subarachnoid erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2319322     DOI: 10.3171/jns.1990.72.4.0634

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  16 in total

Review 1.  The clinical potential of endothelin receptor antagonists in cardiovascular medicine.

Authors:  C J Ferro; D J Webb
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

Review 2.  Cerebral artery myogenic reactivity: The next frontier in developing effective interventions for subarachnoid hemorrhage.

Authors:  Darcy Lidington; Jeffrey T Kroetsch; Steffen-Sebastian Bolz
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-14       Impact factor: 6.200

3.  Intraspinal application of endothelin results in focal ischemic injury of spinal gray matter and restricts the differentiation of engrafted neural stem cells.

Authors:  Richard L Benton; John P Woock; Evelyne Gozal; Michal Hetman; Scott R Whittemore
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

Review 4.  Cerebral vasospasm: a consideration of the various cellular mechanisms involved in the pathophysiology.

Authors:  Jacob Hansen-Schwartz
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 5.  Management of cerebral vasospasm.

Authors:  R Loch Macdonald
Journal:  Neurosurg Rev       Date:  2006-02-24       Impact factor: 3.042

6.  Hemoglobin penetration in the wall of the rabbit basilar artery after subarachnoid hemorrhage and intracisternal hemoglobin injection.

Authors:  P L Foley; N F Kassell; S B Hudson; K S Lee
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

7.  Pharmacological treatment of delayed cerebral ischemia and vasospasm in subarachnoid hemorrhage.

Authors:  Diego Castanares-Zapatero; Philippe Hantson
Journal:  Ann Intensive Care       Date:  2011-05-24       Impact factor: 6.925

Review 8.  "Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.

Authors:  Kendall H Lee; Timothy Lukovits; Jonathan A Friedman
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

9.  The role of nitric oxide in resolution of vasospasam corresponding with cerebral vasospasms after subarachnoid haemorrhage: animal model.

Authors:  Kemal Dizdarević
Journal:  Bosn J Basic Med Sci       Date:  2008-05       Impact factor: 3.363

10.  Oxyhemoglobin-induced expression of R-type Ca2+ channels in cerebral arteries.

Authors:  Timothy E Link; Kentaro Murakami; Micah Beem-Miller; Bruce I Tranmer; George C Wellman
Journal:  Stroke       Date:  2008-04-24       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.